Vijay Agarwal, MD
Founder, President and CEO
Vijay has founded or co-founded multiple companies and has raised tens of millions in funding. He is a tri-fellowship trained brain tumor surgeon and is a pioneer in complex brain tumor surgery. Vijay has published extensively and has three textbooks published or in-press based on his innovative work. He earned a BS from UCLA in Electrical Engineering with a Biomedical Engineering specialization. After medical school, he completed his neurosurgery residency at Duke University Medical Center, with one of the most renowned brain tumor centers in the world. Vijay has devoted his life to improving the lives of patients with brain cancer and has over 20 years in the medical device/biotechnology industry.
Chief Technology Officer
Jeremy has a diverse background in biomedical engineering, development and business growth, spending 20+ years working in medical device product development and manufacturing. He has experience of working with both start-up and multinational companies. His passion is taking early-stage medical concepts from feasibility through to commercialization. Much of Jeremy’s focus has been on complex electromechanical systems, including robotic surgical devices, implantable pacemakers, MRI and ultrasound imaging systems, as well as therapeutic ultrasound applications. He excels at architecting technology road maps that reduce commercialization risks while leading large cross-functional teams on the path to successful solutions applied at each phase of development.
Chief Financial Officer
Terrance has been the Chief Financial Officer of Alpheus Medical since January 2021. Previously he had a 36-year career at Deloitte LLP (26 years as a Partner) with a specialty in Life Sciences and Healthcare Tax. He assisted publicly traded and private companies in a wide range of needs, including IPO’s, early-stage fund-raising, M&A and complex tax planning strategies. As US Global Managing Partner for LifeSciences Tax, Terrance has worked with many of the world’s leading Medical Device and Pharmaceutical companies. He has worked in the Twin Cities, Tokyo, Chicago, and Milwaukee. He is a graduate of the University of South Dakota and a Director of the USD Foundation.
VP, Clinical Operations
Prior to joining Alpheus Medical, Jennifer held several senior-level roles, as well as providing consulting services, for small- and mid-level biotech organizations. Most notably, at Celldex Therapeutics she served as the Global Clinical Project Leader for their glioblastoma program for 13 years. Over her 25-year career, Jennifer has provided leadership within Clinical Development including Clinical Operations and Clinical Science, from protocol development and study start-up through study closure, across multiple early- to late-stage programs in development.
Director of Systems Engineering
Troy has broad expertise across systems engineering, machine design, medical device instrumentation and consumables, design control, and medical device quality. He has helped several medical device startups deliver innovative products to market and holds several patents. Before joining the Alpheus Medical team, Troy provided engineering consulting services to medical device, aerospace, and industrial machinery manufacturers. He held various research and development engineering roles at Verathon, ACIST Medical Systems, Beckman Coulter, Stratasys, and MTS Systems, and has over 25 years of experience developing complex systems.
Steve has extensive experience with complex accounting processes, including stock compensation, revenue recognition, and grant accounting. He also has experience developing financial plans, mergers & acquisitions, developing internal controls, benefits implementation, and establishing banking and legal counsel relationships. Steve has been responsible for the overall financial management of accounting operations for various clients, including financial reporting, cash management, forecasting, board participation and relationships with outside bankers, legal counsel and accounting firms. He has spent most of his career focusing on early-stage technology, life science, and service companies and has over 30 years of Accounting and Finance experience.
BOARD OF DIRECTORS
Klaus Veitinger, MD, PhD
Executive Chairman of the Board Venture Partner, OrbiMed Advisors
Partner, Action Potential Venture Partners
Aaron Sandoski, MBA
Partner, Medtech Convergence Fund
Peter Thompson, MD
General Partner, OrbiMed Advisors
SCIENTIFIC ADVISORY BOARD
Roger Stupp, MD
Chief of Neuro-oncology, Professor of Neurological Surgery, Medicine and Neurology, Feinberg School of Medicine at Northwestern University.
David Reardon, MD
Professor, Medicine, Harvard Medical School; Clinical Director, Center for Neuro-Oncology, Medical Oncology, Dana-Farber Cancer Institute.
Mathias Senge, Ph.D
Photodynamic Therapy World Expert; Chair of Organic Chemistry at TrInity College, Dublin, Ireland.
Walter Stummer, Prof. Dr.
Director, Department of Neurosurgery, University Hospital Münster, Germany; President of the German Society for Neurosurgery.